Increased Circulating CD4⁺CXCR5⁺ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases

Figure 3

The change of CD4⁺CXCR5⁺ lymphocytes from newly diagnosed MDS-AI (PRE) and posttherapy (POST). (a) The quantity of CD4⁺CXCR5⁺ lymphocytes from newly diagnosed MDS-AI (PRE) and posttherapy (POST) (). (b) The PD1 expression of CD4⁺CXCR5⁺ lymphocytes from newly diagnosed MDS-AI (PRE) and posttherapy (POST) ().

(a)

(b)